BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1099 related articles for article (PubMed ID: 8129659)

  • 1. The role of fat-suppression technique and gadopentetate dimeglumine in magnetic resonance imaging evaluation of intraocular tumors and simulating lesions.
    De Potter P; Flanders AE; Shields JA; Shields CL; Gonzales CF; Rao VM
    Arch Ophthalmol; 1994 Mar; 112(3):340-8. PubMed ID: 8129659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of magnetic resonance imaging in children with intraocular tumors and simulating lesions.
    Potter PD; Shields CL; Shields JA; Flanders AE
    Ophthalmology; 1996 Nov; 103(11):1774-83. PubMed ID: 8942869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR imaging of malignant uveal melanoma: role of pulse sequence and contrast agent.
    Mihara F; Gupta KL; Murayama S; Lee N; Bond JB; Haik BG
    AJNR Am J Neuroradiol; 1991; 12(5):991-6. PubMed ID: 1950937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rectal carcinoma: prospective comparison of conventional and gadopentetate dimeglumine enhanced fat-suppressed MR imaging.
    Okizuka H; Sugimura K; Yoshizako T; Kaji Y; Wada A
    J Magn Reson Imaging; 1996; 6(3):465-71. PubMed ID: 8724412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR imaging in retinoblastoma.
    Barkhof F; Smeets M; van der Valk P; Tan KE; Hoogenraad F; Peeters J; Valk J
    Eur Radiol; 1997; 7(5):726-31. PubMed ID: 9166573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Choroidal hemangioma: MR findings and differentiation from uveal melanoma.
    Stroszczynski C; Hosten N; Bornfeld N; Wiegel T; Schueler A; Foerster P; Lemke AJ; Hoffmann KT; Felix R
    AJNR Am J Neuroradiol; 1998 Sep; 19(8):1441-7. PubMed ID: 9763374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of gadopentetate dimeglumine-enhanced, high-resolution magnetic resonance imaging to differentiate among melanin-containing skin tumors.
    Mäurer J; Schlums D; Knollmann FD; Garbe C; Vogl TJ; Bier J; Felix R
    Acad Radiol; 1996 Mar; 3(3):186-91. PubMed ID: 8796663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal MR protocol for hepatic hemangiomas. Comparison of conventional spin-echo sequences with T2-weighted turbo spin-echo and serial gradient-echo (FLASH) sequences with gadolinium enhancement.
    Kim TK; Choi BI; Han JK; Jang HJ; Han MC
    Acta Radiol; 1997 Jul; 38(4 Pt 1):565-71. PubMed ID: 9240679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement and demyelination of the intraorbital optic nerve. Fat suppression magnetic resonance imaging.
    Guy J; Mao J; Bidgood WD; Mancuso A; Quisling RG
    Ophthalmology; 1992 May; 99(5):713-9. PubMed ID: 1594216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of gadopentetate dimeglumine for 1.5-T MR imaging of musculoskeletal masses: comparison with unenhanced T1- and T2-weighted imaging.
    Rosenthal RE; Wozney P
    J Magn Reson Imaging; 1991; 1(5):547-51. PubMed ID: 1790379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visceral metastases from melanoma: findings on MR imaging.
    Premkumar A; Sanders L; Marincola F; Feuerstein I; Concepcion R; Schwartzentruber D
    AJR Am J Roentgenol; 1992 Feb; 158(2):293-8. PubMed ID: 1729784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent and recurrent hyperparathyroidism: assessment with gadopentetate dimeglumine-enhanced MR imaging.
    Seelos KC; DeMarco R; Clark OH; Higgins CB
    Radiology; 1990 Nov; 177(2):373-8. PubMed ID: 2217771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR imaging of optic nerve lesions: value of gadopentetate dimeglumine and fat-suppression technique.
    Hendrix LE; Kneeland JB; Haughton VM; Daniels DL; Szumowski J; Williams AL; Mark LP; Czervionke LF
    AJNR Am J Neuroradiol; 1990; 11(4):749-54. PubMed ID: 2114763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
    Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
    AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra- and paraorbital lesions: value of fat-suppression MR imaging with paramagnetic contrast enhancement.
    Tien RD; Chu PK; Hesselink JR; Szumowski J
    AJNR Am J Neuroradiol; 1991; 12(2):245-53. PubMed ID: 1902021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images.
    Hricak H; Finck S; Honda G; Göranson H
    AJR Am J Roentgenol; 1992 May; 158(5):1043-50. PubMed ID: 1566664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gadolinium-DTPA combined with a fat suppression technique in studies with magnetic resonance at 0.5 T in soft-tissue neoplasms].
    Battolla L; Zampa V; Mascalchi M; Falaschi F; Bagnolesi P; Tessa C; Paolicchi A; Bartolozzi C
    Radiol Med; 1994 Oct; 88(4):353-8. PubMed ID: 7997603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadopentetate dimeglumine-enhanced MR imaging of the postoperative lumbar spine: comparison of fat-suppressed and conventional T1-weighted images.
    Mirowitz SA; Shady KL
    AJR Am J Roentgenol; 1992 Aug; 159(2):385-9. PubMed ID: 1632362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved detection and delineation of head and neck lesions with fat suppression spin-echo MR imaging.
    Tien RD; Hesselink JR; Chu PK; Szumowski J
    AJNR Am J Neuroradiol; 1991; 12(1):19-24. PubMed ID: 1846994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orbit, skull base, and pharynx: contrast-enhanced fat suppression MR imaging.
    Barakos JA; Dillon WP; Chew WM
    Radiology; 1991 Apr; 179(1):191-8. PubMed ID: 2006277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.